Search
for
Sort by
Research 31–60 of 937
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Efficacy of modern methods for assessing the severity of alopecia areata
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Eyebrow and Eyelash Alopecia: A Clinical Review
- Prostaglandin-Induced Hair Growth
- Bimatoprost in the treatment of eyelash hypotrichosis
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Madarosis
- The Latest Innovations in Hair Transplantation
- Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost
- Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Management of Toxicities of Targeted Therapies
- Hair casts
- Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up
- Assessment and Validity of Trichoscopy for Eyebrow Involvement in Lichen Planopilaris: A Case-Control Study
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Frontal Fibrosing Alopecia
- Signposts to the Promised Land in Alopecia Areata
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Clinical characteristics, subtype classification, and prognostic factors of ophiasis: A retrospective study of 150 patients with therapeutic implications
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Madarosis: A marker of many Maladies
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study